A, Transforming growth factor β1 (TGFβ1)/ZEB1/miR-200b feedback loop for endometriotic
epithelial cells in EMT. B, miR-200b/ZEB1 double-negative feedback loop for
endometriotic stromal cells in MET. C, miR-1827/miR-504 model of target genes and
pathways in endometriotic epithelial cells. BMP2 indicates Bone Morphogenetic Protein 2;
COX2 (PTGS2), Prostaglandin-endoperoxide Synthase 2; DNTTIP1,
deoxynucleotidyltransferase terminal interacting protein 1; ELMSAN1, (MIDEAS) ELM2 and
Myb/SANT domain containing 1; EMT, epithelial–mesenchymal transition; FGF2, Fibroblast
Growth Factor 2; FOXO, Forkhead Box; HDAC1, histone deacetylase 1; IL-1B, Interleukin
1B; KLF2/4, Kruppel Like Factor 2/4; MET, mesenchymal–epithelial transition; MMP2,
Matrix Metallopeptidase 2; NQO1, NAD(P)H Quinone dehydrogenase 1; NRP2, neuropilin 2;
OCT4 (POU5F1), POU class 5 homeobox 1; PLXNA4, plexin A4; SEMA, semaphorin; SOX2,
SRY-box 2; MMP2, Matrix Metallopeptidase 2; TGFβ1, transforming growth factor beta 1;
VEGF, Vascular Endothelial Growth Factor; ZEB1, Zinc finger E-box Binding protein 2.